Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Thomas Shrader's Stock Ratings
BTIG Analyst
Thomas Shrader is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 11/05/2025
Overall Average Return
-2.04%
Smart Score
Overall Average Return Percentile
30th
Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
11/05/2025 | STOK | Stoke Therapeutics | $21.94 | 77.76% | $39 → $39 | Reiterates | Buy → Buy | |||
11/04/2025 | ACIU | AC Immune | $3.25 | 146.15% | $8 → $8 | Reiterates | Buy → Buy | |||
10/22/2025 | ARCT | Arcturus Therapeutics | $8.89 | 158.72% | $48 → $23 | Maintains | Buy | |||
10/22/2025 | ALEC | Alector | $1.32 | — | — | Downgrade | Buy → Neutral | |||
10/15/2025 | GANX | Gain Therapeutics | $1.71 | 426.32% | $9 → $9 | Reiterates | Buy → Buy | |||
10/13/2025 | STOK | Stoke Therapeutics | $21.94 | 77.76% | $28 → $39 | Maintains | Buy | |||
10/13/2025 | CMPS | Compass Pathways | $6.60 | 112.12% | $7 → $14 | Maintains | Buy | |||
09/30/2025 | COYA | Coya Therapeutics | $5.90 | 154.24% | $15 → $15 | Reiterates | Buy → Buy | |||
09/29/2025 | HROW | Harrow | $35.71 | 76.42% | $63 → $63 | Reiterates | Buy → Buy | |||
09/25/2025 | ALEC | Alector | $1.32 | 278.79% | $5 → $5 | Reiterates | Buy → Buy | |||
09/24/2025 | HROW | Harrow | $35.71 | 76.42% | $63 → $63 | Reiterates | Buy → Buy | |||
09/08/2025 | DRUG | Bright Minds Biosciences | $51.29 | 40.38% | → $72 | Initiates | → Buy | |||
09/08/2025 | GANX | Gain Therapeutics | $1.71 | 426.32% | $9 → $9 | Reiterates | Buy → Buy | |||
09/08/2025 | ACIU | AC Immune | $3.25 | 146.15% | $8 → $8 | Reiterates | Buy → Buy | |||
08/19/2025 | BHVN | Biohaven | $7.88 | 661.42% | $59 → $60 | Maintains | Buy | |||
08/14/2025 | HROW | Harrow | $35.71 | 76.42% | $62 → $63 | Maintains | Buy | |||
07/10/2025 | VRNA | Verona Pharma | — | — | — | Downgrade | Buy → Neutral | |||
07/01/2025 | INMB | INmune Bio | $1.71 | — | — | Downgrade | Buy → Neutral | |||
04/07/2025 | ALDX | Aldeyra Therapeutics | $4.94 | 82.19% | $11 → $9 | Maintains | Buy | |||
03/24/2025 | OVID | Ovid Therapeutics | $1.29 | 210.08% | $5 → $4 | Maintains | Buy | |||
02/24/2025 | PCVX | Vaxcyte | $41.30 | 287.41% | $160 → $160 | Reiterates | Buy → Buy | |||
01/28/2025 | ARCT | Arcturus Therapeutics | $8.89 | 361.19% | → $41 | Initiates | → Buy | |||
11/26/2024 | ALEC | Alector | $1.32 | 278.79% | $16 → $5 | Maintains | Buy | |||
09/04/2024 | ATHA | Athira Pharma | $4.10 | — | — | Downgrade | Buy → Neutral | |||
09/03/2024 | PCVX | Vaxcyte | $41.30 | 287.41% | $98 → $160 | Maintains | Buy | |||
08/07/2024 | PCVX | Vaxcyte | $41.30 | 137.29% | $98 → $98 | Reiterates | Buy → Buy | |||
06/18/2024 | OVID | Ovid Therapeutics | $1.29 | 287.6% | $11 → $5 | Maintains | Buy | |||
05/31/2024 | ACIU | AC Immune | $3.25 | 146.15% | → $8 | Initiates | → Buy | |||
12/21/2023 | OVID | Ovid Therapeutics | $1.29 | 752.71% | → $11 | Initiates | → Buy | |||
10/03/2023 | PMN | ProMIS Neurosciences | $0.41 | 1869.96% | → $8 | Initiates | → Buy | |||
07/28/2023 | DTIL | Precision BioSciences | $6.58 | -69.58% | $6 → $2 | Maintains | Buy | |||
06/30/2023 | SGTX | Sigilon Therapeutics | — | — | — | Downgrade | Buy → Neutral | |||
06/06/2023 | BHVN | Biohaven | $7.88 | 255.33% | $24 → $28 | Reiterates | → Buy | |||
05/25/2023 | ANNX | Annexon | $3.13 | 123.64% | $15 → $7 | Maintains | Buy | |||
05/18/2023 | COYA | Coya Therapeutics | $5.90 | 154.24% | → $15 | Initiates | → Buy | |||
03/30/2023 | ATHA | Athira Pharma | $4.10 | 143.9% | $33 → $10 | Maintains | Buy | |||
03/28/2023 | BCAB | BioAtla | $0.67 | 1851.95% | $68 → $13 | Maintains | Buy | |||
03/20/2023 | VRNA | Verona Pharma | — | — | $26 → $31 | Maintains | Buy | |||
03/02/2023 | ALEC | Alector | $1.32 | 1112.12% | $54 → $16 | Maintains | Buy | |||
12/20/2022 | VRNA | Verona Pharma | — | — | $17 → $26 | Maintains | Buy | |||
12/02/2022 | BHVN | Biohaven | $7.88 | 204.57% | → $24 | Initiates | → Buy | |||
11/17/2022 | PCVX | Vaxcyte | $41.30 | 67.07% | → $69 | Initiates | → Buy | |||
11/14/2022 | GANX | Gain Therapeutics | $1.71 | 484.8% | $30 → $10 | Maintains | Buy | |||
10/06/2022 | SQZ | SQZ Biotechnologies | — | — | $40 → $15 | Maintains | Buy | |||
10/05/2022 | ABOS | Acumen Pharmaceuticals | $1.98 | 1011.11% | $15 → $22 | Maintains | Buy | |||
09/09/2022 | ANNX | Annexon | $3.13 | 379.23% | → $15 | Initiates | → Buy | |||
07/15/2022 | ABOS | Acumen Pharmaceuticals | $1.98 | 657.58% | → $15 | Initiates | → Buy | |||
05/24/2022 | INMB | INmune Bio | $1.71 | 718.28% | $31 → $14 | Maintains | Buy | |||
05/10/2022 | ATHA | Athira Pharma | $4.10 | 704.88% | → $33 | Initiates | → Buy | |||
10/29/2021 | SGTX | Sigilon Therapeutics | — | — | → $14 | Initiates | → Buy | |||
04/20/2021 | PLRX | Pliant Therapeutics | $1.62 | 3048.15% | → $51 | Initiates | → Buy | |||
04/12/2021 | GANX | Gain Therapeutics | $1.71 | 1654.39% | → $30 | Initiates | → Buy | |||
03/26/2021 | BCAB | BioAtla | $0.67 | 12963.06% | $47 → $87 | Maintains | Buy | |||
03/26/2021 | GXGX | GX Acquisition | — | — | → $16 | Initiates | → Buy | |||
03/08/2021 | ONCS | OncoSec Medical | — | — | → $10 | Initiates | → Buy | |||
03/08/2021 | NUVB | Nuvation Bio | $4.76 | 236.13% | → $16 | Initiates | → Buy | |||
02/03/2021 | VYGR | Voyager Therapeutics | $4.16 | — | — | Downgrade | Buy → Neutral | |||
01/11/2021 | BCAB | BioAtla | $0.67 | 6957.06% | → $47 | Initiates | → Buy | |||
11/24/2020 | SQZ | SQZ Biotechnologies | — | — | → $40 | Initiates | → Buy | |||
11/18/2020 | EIDX | Eidos Therapeutics | — | — | — | Downgrade | Buy → Neutral | |||
10/16/2020 | DNLI | Denali Therapeutics | $15.46 | — | — | Downgrade | Buy → Neutral | |||
09/23/2020 | VCNX | Vaccinex | $0.51 | — | — | Downgrade | Buy → Neutral | |||
09/15/2020 | ETNB | 89bio | $14.95 | 287.96% | $51 → $58 | Maintains | Buy | |||
09/01/2020 | INMB | INmune Bio | $1.71 | 1244.32% | → $23 | Initiates | → Buy | |||
09/01/2020 | CMPI | Checkmate Pharmaceuticals | — | — | → $29 | Initiates | → Buy | |||
04/03/2020 | GERN | Geron | $1.24 | 141.94% | $4 → $3 | Maintains | Buy | |||
08/09/2019 | DNLI | Denali Therapeutics | $15.46 | 94.05% | → $30 | Initiates | → Buy | |||
08/02/2019 | ACOR | Acorda Therapeutics | — | — | $12 → $7 | Maintains | Hold | |||
04/18/2019 | EIDX | Eidos Therapeutics | — | — | → $38 | Initiates | → Buy | |||
02/21/2019 | BIIB | Biogen | $147.96 | 133.85% | $397 → $346 | Downgrade | Buy → Hold | |||
02/13/2019 | GERN | Geron | $1.24 | 222.58% | → $4 | Initiates | → Buy | |||
08/07/2018 | ACOR | Acorda Therapeutics | — | — | $15 → $25 | Maintains | Hold | |||
08/07/2018 | BIIB | Biogen | $147.96 | 166.3% | → $394 | Reinstates | → Buy | |||
02/22/2018 | MNTA | Momenta Pharmaceuticals | — | — | — | Upgrade | Hold → Buy | |||
11/16/2017 | ACOR | Acorda Therapeutics | — | — | — | Downgrade | Buy → Hold | |||
10/17/2017 | BIIB | Biogen | $147.96 | — | — | Upgrade | Hold → Buy | |||
10/05/2017 | MNTA | Momenta Pharmaceuticals | — | — | — | Downgrade | Buy → Hold | |||
10/04/2017 | MNTA | Momenta Pharmaceuticals | — | — | — | Downgrade | Buy → Hold | |||
06/30/2017 | WINT | Windtree Therapeutics | $0.08 | — | — | Downgrade | Buy → Hold | |||
05/22/2017 | VRNA | Verona Pharma | — | — | → $22 | Initiates | → Buy | |||
05/08/2017 | TOCA | Tocagen | — | — | — | Initiates | → Buy | |||
03/03/2017 | KITE | Kite Pharma | — | — | — | Downgrade | Buy → Hold | |||
08/19/2016 | GERN | Geron | $1.24 | — | — | Initiates | → Neutral | |||
03/04/2016 | GI | EndoChoice Holdings | — | — | $16 → $10 | Maintains | Buy | |||
03/04/2016 | ARMH | ARM Holdings | $71.52 | — | — | Downgrade | Buy → Hold | |||
03/04/2016 | VTAE | Vitae Pharmaceuticals | — | — | — | Downgrade | Buy → Hold |
